Biotechnology
Healthcare
Investing News
Market News
Technology
The Market Buzz
Creative Medical Technology Reports IRB Approval for Phase ½ Clinical Trial of Novel Cell Therapy to Treat Type 1 Diabetes
Creative Medical Technology Holdings, Inc. (NASDAQ: CELZ) reported that it has received Institutional Review Board approval to proceed with its clinical trial to treat Type 1 Diabetes with its...